Results 91 to 100 of about 4,399 (136)

Volumetric Analysis of Navigation-Guided Orbital Decompression in Graves' Orbitopathy: A Case Report. [PDF]

Life (Basel)
Ruiz-de-Leon G, Ochandiano S, Alvarez-Mokthari S, Benito-Anguita M, Nieva-Pascual I, Cifuentes-Canorea P, Sanjuan-de-Moreta G, Salmeron JI, Navarro-Cuellar I, Navarro-Cuellar C, Tousidonis M.   +10 more
europepmc   +1 more source

Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves' Orbitopathy: A Proteomic Study. [PDF]

Invest Ophthalmol Vis Sci
Hötte GJ, Kolijn PM, de Bie M, Swagemakers SMA, van der Spek PJ, de Keizer ROB, Goudsmit BFJ, Visser WE, van Hagen PM, Paridaens D, Dik WA.   +10 more
europepmc   +1 more source

Nicotinamide N-Methyltransferase in the Inflammatory Pathogenesis of Graves' Orbitopathy. [PDF]

Invest Ophthalmol Vis Sci
Cho D, Choi SH, Yoon JS, Ko J.
europepmc   +1 more source

Unilateral Graves' Orbitopathy Followed by Hashimoto's Hypothyroidism: Highlighting Micronutrient Influence in Thyroid Autoimmunity. [PDF]

Cureus
Kermaj M, Lekbello M, Blushi M, Ylli D, Ylli A.   +4 more
europepmc   +1 more source

Secukinumab in Moderate-to-Severe Graves Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

J Clin Endocrinol Metab
Wolf J, Lorenz K, Othman AE, Beck A, Michel HM, Grauhan L, Elflein H, Luffy M, Eckstein A, Lahner H, Schittkowski M, Horn M, Lagrèze WA, Bleul T, Pitz S, Vorländer C, Pieterse CC, Porter B, Clemens A, Draikiwicz S, Reinhardt M, Kahaly GJ.   +21 more
europepmc   +1 more source

Retraction: Preliminary Evidence From an Original Study Suggests Combustion, Not Nicotine, Drives Risk and Complications of Graves' Orbitopathy. [PDF]

Cureus
Acanfora M, Vassallo A.
europepmc   +1 more source

Age-dependent diagnostic and treatment response prediction of TBII and TSI in Graves' orbitopathy: integration with orbital MRI biomarkers. [PDF]

Front Immunol
Song C, Wang X, Ma Q, Yu G, Zhu Y, Huang Z, Chen T, Huang K, Hai Y, Chen H, Duan Y, Shen J.   +11 more
europepmc   +1 more source

Role of SerpinA3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts. [PDF]

Invest Ophthalmol Vis Sci
Kim MS, Choi SH, Park HY, Jang SY, Ko J, Kim JW, Yoon JS.   +6 more
europepmc   +1 more source

Current concepts of tocilizumab efficacy in active moderate-to-severe corticosteroid-resistant cases of Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Boutzios G, Nikolopoulou A, Chatzi S, Tzioufas AG, Goules AV.   +4 more
europepmc   +1 more source